Mirrored from Sad Lad, 28-3-2017 (88min). This hard-hitting documentary, Cut Poison Burn, takes a rare look at what happens when a cancer patient questions the “standard of care” and attempts to make personal choices promising the best results for the patient and not the cancer industry.
U.S.’s War on Cancer lead to almighty dollar
Sadly, according to the DVD, all paths in the U.S.’s ‘War on Cancer’ lead to the almighty dollar
Unless you’ve personally walked the path – or have accompanied a loved one – through this brutally convoluted, hostile maze, you probably have no clue as to the hidden and well-disguised demons awaiting the unsuspecting visitor.
And so in lies the value of this bold and daring documentary.
The opportunity to catch a glimpse of the path before you or a loved one join the 1-in-3 women or 1-in-2 men who will be forced to walk it during their lifetime.
And perhaps the opportunity to make a difference – today and not tomorrow.
In Cut Poison Burn, you’ll glean an insider’s view of America’s so-called ‘War on Cancer’ and the cancer industry while meeting its various players:
The federal government who, despite claiming they will “leave no stone unturned” to fight the nasty enemy, instead spends its precious time and resources persecuting innocent innovators whom they consider “quacks”
The drug companies threatened by alternative cancer treatments that can’t be patented or produce sufficient profits
The powerful “non-profit” organizations that clearly have their eye on the money instead of cancer victims’ best interests
If you doubt that it’s all about the money, consider this intriguing fact…
According to the documentary, ONE cancer patient, from diagnosis to death is typically worth a whopping $350,000 and in some cases, over a million dollars, to the lucrative cancer industry.
Can you imagine a more perfect setup for Big Business?
“Why Are We Losing the War on Cancer?”
Despite over $2.7 trillion spent on research and treatment, 14,800,000 Americans have died from cancer since 1971. In 2009 alone, 565,000 – or 1,548 people every day – lost their lives to the dreaded disease. And in the next 3 years, more individuals will die from cancer than ALL the U.S. soldier deaths from EVERY war since the American Revolution. What’s going on?
We weren’t supposed to lose. In 1971, President Richard Nixon declared the ‘War on Cancer’. And with that declaration, the American Cancer Program officially launched.
With an initial appointment of $1.6 billion for the first 3 years alone, the program shouldn’t have failed – but it has. And miserably at that.
Perhaps Charles B. Simone, M.MS., M.D., Founder of the Simone Protective Cancer Center sums up this dismal failure best:
“Little or no progress in the treatment of adult cancers has been made. A man or woman who gets prostate or breast cancer today will live as long as the person who developed these same cancers in 1920. Nothing we’ve done in a century has substantially reduced deaths.”
Dr. Simone agrees that certain cancers have been helped – lymphomas, childhood leukemia, Hodgkin’s, and the type of testicular cancer that afflicted Lance Armstrong.
But the more common cancers affecting average citizens – colon, breast, prostate, and lung – have not been aided by the War on Cancer’s conventional treatments.
Dr. Burzynski’s Groundbreaking, Yet Forbidden Treatment
The Navarro’s journey took them to the steps of the Burzynski Research Institute in Houston, Texas, founded by the renowned Stanislaw R. Burzynski, M.D., Ph.D.
The American Cancer Society: For the People… or for Corporate America?
“Who does the American Cancer Society represent? The answer with
all non-profits is defined by where their financial support comes from.”
- Jonathan Emord, Constitutional Lawyer
The American Cancer Society (ACS) is one the world’s wealthiest non-profit organizations with total assets of $2,317,471,000.
You may be wondering… if it’s non-profit, where does it get its generous funding?
According to the documentary, the answer lies in a long history of partnerships with deep-pocketed corporations, including Big Tobacco.
Here’s an example of one of their mutually-benefiting, “revolving door” relationships…
The first director of the ACS, Clarence Cook Little, resigned in 1954 to become the Scientific Director of the Tobacco Industry Research Council.
At the time, there were ACS board members working “hand-in-glove” with tobacco industry advertising firms, who were, in essence, running the American Cancer Society’s advertising.